🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Traumatic brain injury (TBI) is a common condition with high degree of morb...
Status
Unknown
Location
Cambridge University Hospital NHS Trust
Start Date
2017-10
Trial ID
NCT02997371
Treatments Being Tested
This study tests whether an asthma medication called dupilumab can help peo...
Status
Recruiting
Location
Sir Charles Gairdner Hospital
Start Date
2026-01-29
Trial ID
NCT07309614
Treatments Being Tested
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
This is a pivotal phase 3 study designed to support an indication for the r...
Status
Completed
Location
SEC Clinical Research LLC
Start Date
2019-12-12
Trial ID
NCT04023552
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety, pharmacokinet...
Status
Completed
Location
Renstar Medical Research
Start Date
2017-02-28
Trial ID
NCT02905331
Treatments Being Tested
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested
JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody. This is a ...
Status
Completed
Location
Beijing Anzhen Hospital，Capital Medical University
Start Date
2022-02-28
Trial ID
NCT05532800